Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema

被引：15

作者：

Montinaro, Vincenzo ^{[1
,2
]}

Loizzo, Giuliana ^{[1
,2
]}

Zito, Anna ^{[1
,2
]}

Castellano, Giuseppe ^{[1
,2
]}

Gesualdo, Loreto ^{[1
,2
]}

机构：

[1] Univ Aldo Moro, Azienda Osped Univ Consorziale Policlin, Div Nephrol Transplant & Dialysis, Bari, Italy

[2] Univ Aldo Moro, Azienda Osped Univ Consorziale Policlin, Ctr Diag & Treatment Hereditary Angioedema, Bari, Italy

来源：

AMERICAN JOURNAL OF EMERGENCY MEDICINE | 2013年 / 31卷 / 08期

关键词：

HEREDITARY ANGIOEDEMA; RECEPTOR ANTAGONIST; BRADYKININ;

D O I：

10.1016/j.ajem.2013.04.024

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Angioedema (AE) is related to the activation of the contact phase system-kallikrein and generation of bradykinin. Different types of AE are recognized: hereditary or acquired deficit of the C1 inhibitor, drug-related, or idiopathic. Treatment of idiopathic nonhistaminergic AE (IAE) is difficult because corticosteroids, antihistamine drugs, and adrenalin are inefficacious. We describe a patient with an IAE and an acute attack of facial AE that was successfully treated with the bradykinin receptor antagonist icatibant. This case report strengthens the relevance of bradykinin formation in IAE and underlines the effectiveness of icatibant as a therapeutic option in acute IAE.

引用

页码：1295.e5 / 1295.e6

页数：2

共 50 条

[41] EnalaprilLaryngeal angioedema treated with icatibant in an elderly patient: case report
Reactions Weekly, 2015, 1581 (1) : 137 - 137
[42] Successful treatment of chronic idiopathic urticaria & Angioedema (CIU), with Xolair (omalizumab)
Shapiro, C. A.
Kapetanos, N. S.
Sarmiento, E.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S274 - S274
[43] Successful long term treatment of 141 attacks in a patient with hereditary angioedema with the bradykinin B2 receptor antagonist icatibant
Greve, J.
Bas, M.
Schuler, P.
Schipper, J.
Lang, S.
Hoffmann, T.
ALLERGY, 2009, 64 : 281 - 281
[44] SUDDEN ONSET FACIAL SWELLING IN A PATIENT WITH IDIOPATHIC PULMONARY FIBROSIS MIMICKING ANGIOEDEMA
Wilcott, Robert
Salick, Muhammad
Wazir, Ali
Neu, Kristoffer
CHEST, 2019, 156 (04) : 1384A - 1384A
[45] Contraersy to use icatibant for prophylaxisin in angioedema
Ocampo, J.
Floccard, B.
Bouillet, L.
Rimmele, T.
REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2015, 62 (09): : 543 - 543
[46] IN BRIEF Icatibant (Firazyr) for Hereditary Angioedema
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1378): : 96 - 96
[47] Icatibant in hereditary angioedema: news and challenges
Bouillet, Laurence
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 267 - 272
[48] Icatibant in the treatment of angiotensin II receptor blocker induced angioedema
Strassen, U.
Bas, M.
Hoffmann, T.
Greve, J.
ALLERGY, 2012, 67 : 359 - 359
[49] Short-term prophylactic treatment of hereditary angioedema with icatibant
Marques, L.
Domingo, D.
Maravall, F. J.
Clotet, J.
ALLERGY, 2010, 65 (01) : 137 - 138
[50] Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema
Farkas, Henriette
Reshef, Avner
Aberer, Werner
Caballero, Teresa
McCarthy, Laura
Hao, James
Nothaft, Wolfram
Schranz, Jennifer
Bernstein, Jonathan A.
Li, H. Henry
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1671 - +

← 1 2 3 4 5 →